Literature DB >> 29900994

Comparison of Effects of Leukocyte-Rich and Leukocyte-Poor Platelet-Rich Plasma on Pain and Functionality in Patients With Lateral Epicondylitis.

Melek Yerlikaya1, Havva Talay Çaliş2, Serap Tomruk Sütbeyaz2, Hatice Sayan2, Nurdan Ibiş2, Ali Koç2, Çiğdem Karakükçü2.   

Abstract

OBJECTIVES: This study aims to compare the effect of leukocyte concentration in platelet-rich plasma (PRP) on pain, functionality and post-injection local inflammatory reactions in patients with lateral epicondylitis. PATIENTS AND METHODS: The study included 90 patients (26 males, 64 females; mean age 38.6 years; range 18 to 75 years) with lateral epicondylitis- related pain visual analog scale (VAS) score of ≥5 for more than three months. Patients were randomly assigned into three groups. Normal saline (1.5 mL) was injected in group 1 (control group) while a single dose of leukocyte-poor-PRP (1.5 mL) and leukocyte-rich-PRP (1.5 mL) were injected in groups 2 and 3, respectively. An exercise program was recommended to patients in all three groups. Patients were assessed according to VAS, Patient-Rated Tennis Elbow Evaluation, grip dynamometer and pinchmeter, extensor tendon thickness and cortical derangement at baseline and at fourth and eighth weeks after therapy. All patients were questioned regarding paracetamol use and adverse effects after therapy.
RESULTS: No significant differences were detected between groups regarding VAS, Patient-Rated Tennis Elbow Evaluation, grip and pinch measurements, extensor tendon thickness and cortical derangement (p>0.05). In intra-group comparisons, VAS and Patient-Rated Tennis Elbow Evaluation scores obtained at fourth and eighth weeks were significantly decreased in all groups when compared to baseline values (p>0.05). Again, there was no significant difference in the control visit at eighth week when compared to baseline. Assessment of grip and pinch measurements revealed that values obtained at fourth and eighth weeks were significantly increased compared to baseline in all three groups (p<0.05). In leukocyte-rich-PRP group, a significant increase was detected in the values obtained at eighth week compared to those obtained at fourth week, but no significant change was detected in other groups. No significant difference was detected in extensor tendon thickness in any group. No significant difference was detected between groups in terms of paracetamol use and post-injection reactions.
CONCLUSION: According to our study findings, lateral epicondylitis does not seem to affected either leukocyte-rich-PRP or leukocyte-poor-PRP on pain and function in the short term. Leukocyte concentration had no association with post-injection local inflammatory reactions.

Entities:  

Keywords:  Lateral epicondylitis; platelet-rich plasma; tennis elbow

Year:  2017        PMID: 29900994      PMCID: PMC5864175          DOI: 10.5606/ArchRheumatol.2018.6336

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  13 in total

1.  Platelet-rich plasma (PRP): what is PRP and what is not PRP?

Authors:  R E Marx
Journal:  Implant Dent       Date:  2001       Impact factor: 2.454

2.  Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial.

Authors:  Christos Thanasas; George Papadimitriou; Charalambos Charalambidis; Ilias Paraskevopoulos; Athanasios Papanikolaou
Journal:  Am J Sports Med       Date:  2011-08-02       Impact factor: 6.202

3.  Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up.

Authors:  Joost C Peerbooms; Jordi Sluimer; Daniël J Bruijn; Taco Gosens
Journal:  Am J Sports Med       Date:  2010-02       Impact factor: 6.202

4.  Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis.

Authors:  Jonathan C Riboh; Bryan M Saltzman; Adam B Yanke; Lisa Fortier; Brian J Cole
Journal:  Am J Sports Med       Date:  2015-04-29       Impact factor: 6.202

5.  Inefficacy of ultrasound-guided local injections of autologous conditioned plasma for recent epicondylitis: results of a double-blind placebo-controlled randomized clinical trial with one-year follow-up.

Authors:  Bernard Montalvan; Patrick Le Goux; Shahnaz Klouche; Delphine Borgel; Philippe Hardy; Maxime Breban
Journal:  Rheumatology (Oxford)       Date:  2015-09-08       Impact factor: 7.580

6.  Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections.

Authors:  Leon Creaney; Andrew Wallace; Mark Curtis; David Connell
Journal:  Br J Sports Med       Date:  2011-03-15       Impact factor: 13.800

7.  Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid.

Authors:  Tímea Spaková; Ján Rosocha; Marek Lacko; Denisa Harvanová; Ahmed Gharaibeh
Journal:  Am J Phys Med Rehabil       Date:  2012-05       Impact factor: 2.159

8.  Platelet-rich plasma for the treatment of lateral epicondylitis: sonographic assessment of tendon morphology and vascularity (pilot study).

Authors:  Salma Chaudhury; Mauricio de La Lama; Ronald S Adler; Lawrence V Gulotta; Brendan Skonieczki; Anthony Chang; Peter Moley; Frank Cordasco; Jo Hannafin; Stephen Fealy
Journal:  Skeletal Radiol       Date:  2012-09-22       Impact factor: 2.199

9.  Can platelet-rich plasma enhance tendon repair? A cell culture study.

Authors:  Marieke de Mos; Anna E van der Windt; Holger Jahr; Hans T M van Schie; Harrie Weinans; Jan A N Verhaar; Gerjo J V M van Osch
Journal:  Am J Sports Med       Date:  2008-03-07       Impact factor: 6.202

10.  Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use.

Authors:  Jean-François Kaux; Pierre Drion; Jean-Louis Croisier; Jean-Michel Crielaard
Journal:  J Stem Cells Regen Med       Date:  2015-05-30
View more
  13 in total

1.  CORR Synthesis: What Is the Role of Platelet-rich Plasma Injection in the Treatment of Tendon Disorders?

Authors:  Mark W LaBelle; Randall E Marcus
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.176

2.  Clinical efficacy of platelet-rich plasma in the treatment of lateral epicondylitis: a systematic review and meta-analysis of randomized placebo-controlled clinical trials.

Authors:  Mario Simental-Mendía; Félix Vilchez-Cavazos; Neri Álvarez-Villalobos; Jaime Blázquez-Saldaña; Víctor Peña-Martínez; Gregorio Villarreal-Villarreal; Carlos Acosta-Olivo
Journal:  Clin Rheumatol       Date:  2020-02-26       Impact factor: 2.980

Review 3.  In vitro evidence supporting applications of platelet derivatives in regenerative medicine.

Authors:  Ilaria Giusti; Sandra D'Ascenzo; Guido Macchiarelli; Vincenza Dolo
Journal:  Blood Transfus       Date:  2019-10-08       Impact factor: 3.443

Review 4.  Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain.

Authors:  Teemu V Karjalainen; Michael Silagy; Edward O'Bryan; Renea V Johnston; Sheila Cyril; Rachelle Buchbinder
Journal:  Cochrane Database Syst Rev       Date:  2021-09-30

5.  Effects of platelet-rich plasma injection on pain, range of motion, and disability in adhesive capsulitis: A prospective, randomized-controlled study.

Authors:  Çağlar Karabaş; Havva Talay Çalış; Ulaş Serkan Topaloğlu; Çiğdem Karakükçü
Journal:  Turk J Phys Med Rehabil       Date:  2021-12-01

6.  Functional Outcome of Platelet-Rich Plasma (PRP) Intra-lesional Injection for Tennis Elbow - A Prospective Cohort Study.

Authors:  Madhavan Paramanantham; Hariprasad Seenappa; Sagar Venkataraman; Arun H Shanthappa
Journal:  Cureus       Date:  2022-03-08

Review 7.  Effectiveness of Platelet-Rich Plasma for Lateral Epicondylitis: A Systematic Review and Meta-analysis Based on Achievement of Minimal Clinically Important Difference.

Authors:  Pawel Niemiec; Karol Szyluk; Alicja Jarosz; Tomasz Iwanicki; Anna Balcerzyk
Journal:  Orthop J Sports Med       Date:  2022-04-08

Review 8.  Comparative analysis of leucocyte poor vs leucocyte rich platelet-rich plasma in the management of lateral epicondylitis: Systematic review & meta-analysis of randomised controlled trials.

Authors:  Sathish Muthu; Sandeep Patel; Preethi Selvaraj; Madhan Jeyaraman
Journal:  J Clin Orthop Trauma       Date:  2021-05-21

9.  Platelet-rich Plasma or Autologous Blood Do Not Reduce Pain or Improve Function in Patients with Lateral Epicondylitis: A Randomized Controlled Trial.

Authors:  Lasse Linnanmäki; Kari Kanto; Teemu Karjalainen; Olli V Leppänen; Janne Lehtinen
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

10.  Effect of platelet-rich plasma on the degenerative rotator cuff tendinopathy according to the compositions.

Authors:  Sang Jun Kim; Seung Mi Yeo; Soo Jin Noh; Chul-Won Ha; Byung Chan Lee; Hyo Sun Lee; Sun Jeong Kim
Journal:  J Orthop Surg Res       Date:  2019-12-02       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.